Literature DB >> 26555546

Long non-coding RNA MVIH is associated with poor prognosis and malignant biological behavior in breast cancer.

Bo Lei1, Shou-Ping Xu1, Xiao-Shuan Liang1, Yi-Wen Li2, Jin-Feng Zhang1, Guo-Qiang Zhang3, Da Pang4.   

Abstract

In recent years, with the development of transcriptomics, the effect of long non-coding RNAs (LncRNAs) on the regulation of biological processes is being elucidated. LncRNAs play an important role in tumor occurrence and development. LncRNA associated with microvascular invasion in hepatocellular carcinoma (LncRNA MVIH) was first identified in hepatocellular carcinoma and is associated with angiogenesis, tumor growth and metastasis upregulation, and poor recurrence-free survival. MVIH has an important role in non-small cell lung cancer, in which it promotes cell proliferation and metastasis, and high MVIH expression indicates poor overall survival. However, the involvement of MVIH in breast cancer is unclear. Our research revealed that the expression levels of MVIH in breast cancer tissues were higher than in adjacent noncancerous tissues, and high MVIH expression was correlated with Ki67 expression. Moreover, breast cancer patients with high MVIH expression levels showed poor overall survival and disease-free survival. Multivariate analysis results indicated that MVIH was an independent prognostic factor in breast cancer. In addition, upregulated MVIH expression levels promoted cell proliferation and cell cycle, and inhibited cell apoptosis, while reduced MVIH expression showed the converse. In summary, our findings suggest that MVIH may have an important role in breast cancer and may serve as a new biomarker and a potential therapeutic target.

Entities:  

Keywords:  Biomarker; Breast cancer; Long non-coding RNA; MVIH; Prognosis

Mesh:

Substances:

Year:  2015        PMID: 26555546     DOI: 10.1007/s13277-015-4360-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.

Authors:  Ruilei Liu; Jie Li; Yuanhui Lai; Yi Liao; Ruiming Liu; Wanshou Qiu
Journal:  Int J Biol Macromol       Date:  2015-08-11       Impact factor: 6.953

Review 2.  Breast cancer statistics, 2013.

Authors:  Carol DeSantis; Jiemin Ma; Leah Bryan; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-10-01       Impact factor: 508.702

3.  Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans.

Authors:  Fu Yang; Ling Zhang; Xi-song Huo; Ji-hang Yuan; Dan Xu; Sheng-xian Yuan; Nan Zhu; Wei-ping Zhou; Guang-shun Yang; Yu-zhao Wang; Jing-li Shang; Chun-fang Gao; Feng-rui Zhang; Fang Wang; Shu-han Sun
Journal:  Hepatology       Date:  2011-09-06       Impact factor: 17.425

4.  Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer.

Authors:  Philip Jonsson; Cristian Coarfa; Fahmi Mesmar; Tal Raz; Kimal Rajapakshe; John F Thompson; Preethi H Gunaratne; Cecilia Williams
Journal:  Mol Endocrinol       Date:  2015-10-01

5.  A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation.

Authors:  Guohui Wan; Xiaoxiao Hu; Yunhua Liu; Cecil Han; Anil K Sood; George A Calin; Xinna Zhang; Xiongbin Lu
Journal:  EMBO J       Date:  2013-10-04       Impact factor: 11.598

Review 6.  The hallmarks of cancer: a long non-coding RNA point of view.

Authors:  Tony Gutschner; Sven Diederichs
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

7.  Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1).

Authors:  J Huang; N Zhou; K Watabe; Z Lu; F Wu; M Xu; Y-Y Mo
Journal:  Cell Death Dis       Date:  2014-01-23       Impact factor: 8.469

8.  H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.

Authors:  Constance Vennin; Nathalie Spruyt; Fatima Dahmani; Sylvain Julien; François Bertucci; Pascal Finetti; Thierry Chassat; Roland P Bourette; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Oncotarget       Date:  2015-10-06

9.  GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer.

Authors:  M Mourtada-Maarabouni; M R Pickard; V L Hedge; F Farzaneh; G T Williams
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer.

Authors:  John R Prensner; Wei Chen; Matthew K Iyer; Qi Cao; Teng Ma; Sumin Han; Anirban Sahu; Rohit Malik; Kari Wilder-Romans; Nora Navone; Christopher J Logothetis; John C Araujo; Louis L Pisters; Ashutosh K Tewari; Christine E Canman; Karen E Knudsen; Naoki Kitabayashi; Mark A Rubin; Francesca Demichelis; Theodore S Lawrence; Arul M Chinnaiyan; Felix Y Feng
Journal:  Cancer Res       Date:  2014-01-28       Impact factor: 12.701

View more
  15 in total

Review 1.  Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.

Authors:  Sona Uramova; Peter Kubatka; Zuzana Dankova; Andrea Kapinova; Barbora Zolakova; Marek Samec; Pavol Zubor; Anthony Zulli; Vanda Valentova; Taeg Kyu Kwon; Peter Solar; Martin Kello; Karol Kajo; Dietrich Busselberg; Martin Pec; Jan Danko
Journal:  EPMA J       Date:  2018-11-12       Impact factor: 6.543

2.  Long non-coding RNA NKILA inhibits proliferation and migration of lung cancer via IL-11/STAT3 signaling.

Authors:  Dongmei Liu; Xiuyan Shi
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

3.  Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma.

Authors:  Ahmed Hassan Fawzi El-Tawdi; Marwa Matboli; Hanan Hussein Shehata; Fathy Tash; Nashwa El-Khazragy; Ahmed El-Sayed Mansour Azazy; Omar Abdel-Rahman
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

4.  Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.

Authors:  Song Xu; Xiao-Ming Yi; Chao-Peng Tang; Jing-Ping Ge; Zheng-Yu Zhang; Wen-Quan Zhou
Journal:  Oncol Rep       Date:  2016-05-09       Impact factor: 3.906

Review 5.  Current Status of Long Non-Coding RNAs in Human Breast Cancer.

Authors:  Stefanie Cerk; Daniela Schwarzenbacher; Jan Basri Adiprasito; Michael Stotz; Georg C Hutterer; Armin Gerger; Hui Ling; George Adrian Calin; Martin Pichler
Journal:  Int J Mol Sci       Date:  2016-09-06       Impact factor: 5.923

6.  Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy.

Authors:  Carsten Nieder; Astrid Dalhaug; Ellinor Haukland; Bard Mannsaker; Adam Pawinski
Journal:  J Clin Med Res       Date:  2017-01-25

Review 7.  Deciphering the roles of lncRNAs in breast development and disease.

Authors:  John Lalith Charles Richard; Pieter Johan Adam Eichhorn
Journal:  Oncotarget       Date:  2018-02-28

8.  The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.

Authors:  Tian Tian; Meng Wang; Shuai Lin; Yan Guo; Zhiming Dai; Kang Liu; Pengtao Yang; Cong Dai; Yuyao Zhu; Yi Zheng; Peng Xu; Wenge Zhu; Zhijun Dai
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-03       Impact factor: 8.886

Review 9.  Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease.

Authors:  Bo Yu; Shusheng Wang
Journal:  Theranostics       Date:  2018-06-08       Impact factor: 11.556

10.  lncRNA PICART1 alleviates progression of cervical cancer by upregulating TCF21.

Authors:  Yunxia Zhao; Xiuxian Dong; Rong Hou
Journal:  Oncol Lett       Date:  2020-03-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.